HLS Therapeutics Inc. (TSX:HLS)
Canada · Delayed Price · Currency is CAD 4.650
0.00 (0.00%)
May 1, 2026, 3:59 PM EST
HLS Therapeutics Market Cap
HLS Therapeutics has a market cap or net worth of CAD 145.42 million as of May 1, 2026. Its market cap has increased by 6.87% in one year.
Market Cap
145.42M
Enterprise Value
197.66M
Revenue
76.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.65
Market Cap Chart
Since March 15, 2018, HLS Therapeutics's market cap has decreased from 317.91M to 145.42M, a decrease of -54.26%. That is a compound annual growth rate of -9.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 145.42M | -3.53% |
| Dec 31, 2025 | 150.74M | 20.64% |
| Dec 31, 2024 | 124.95M | -1.37% |
| Dec 29, 2023 | 126.68M | -60.20% |
| Dec 30, 2022 | 318.33M | -34.60% |
| Dec 31, 2021 | 486.77M | -14.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurora Cannabis | 276.12M |
| Organigram Global | 261.58M |
| Auxly Cannabis Group | 207.70M |
| Cardiol Therapeutics | 200.25M |
| Cannara Biotech | 173.86M |
| BioSyent | 167.11M |
| Ascend Wellness Holdings | 144.29M |
| Medexus Pharmaceuticals | 126.82M |